540 related articles for article (PubMed ID: 21051502)
1. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
[TBL] [Abstract][Full Text] [Related]
2. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
[TBL] [Abstract][Full Text] [Related]
3. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
4. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
Osther PJ
Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
[TBL] [Abstract][Full Text] [Related]
5. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
7. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
8. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
Murayama T; Taguchi H
Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
[TBL] [Abstract][Full Text] [Related]
12. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
[TBL] [Abstract][Full Text] [Related]
13. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
[TBL] [Abstract][Full Text] [Related]
14. Sodium restriction as initial conservative treatment for urinary stone disease.
Yun SJ; Ha YS; Kim WT; Kim YJ; Lee SC; Kim WJ
J Urol; 2010 Oct; 184(4):1372-6. PubMed ID: 20723924
[TBL] [Abstract][Full Text] [Related]
15. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
[TBL] [Abstract][Full Text] [Related]
17. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
[TBL] [Abstract][Full Text] [Related]
18. Oxalate intake and the risk for nephrolithiasis.
Taylor EN; Curhan GC
J Am Soc Nephrol; 2007 Jul; 18(7):2198-204. PubMed ID: 17538185
[TBL] [Abstract][Full Text] [Related]
19. [Diurnal variation in plasma oxalate concentration and oxalate clearance in calcium oxalate stone formers with special reference to the effect of oxalate loading].
Kinoshita N
Hinyokika Kiyo; 1987 Sep; 33(9):1331-41. PubMed ID: 3434488
[TBL] [Abstract][Full Text] [Related]
20. Diet and renal stone formation.
Trinchieri A
Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
